Suppr超能文献

MAMLD1 与性发育差异/障碍:最新研究进展。

MAMLD1 and Differences/Disorders of Sex Development: An Update.

机构信息

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.

Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.

出版信息

Sex Dev. 2022;16(2-3):126-137. doi: 10.1159/000519298. Epub 2021 Oct 25.

Abstract

MAMLD1 (alias CXorf6) was first documented in 2006 as a causative gene of 46,XY differences/disorders of sex development (DSD). MAMLD1/Mamld1 is expressed in the fetal testis and is predicted to enhance the expression of several Leydig cell-specific genes. To date, hemizygous MAMLD1 variants have been identified in multiple 46,XY individuals with hypomasculinized external genitalia. Pathogenic MAMLD1 variants are likely to cause genital abnormalities at birth and are possibly associated with age-dependent deterioration of testicular function. In addition, some MAMLD1 variants have been identified in 46,XX individuals with ovarian dysfunction. However, recent studies have raised the possibility that MAMLD1 variants cause 46,XY DSD and ovarian dysfunction as oligogenic disorders. Unsolved issues regarding MAMLD1 include the association between MAMLD1 variants and 46,XX testicular DSD, gene-gene interactions in the development of MAMLD1-mediated DSD, and intracellular functions of MAMLD1.

摘要

MAMLD1(又名 CXorf6)于 2006 年首次被记录为导致 46,XY 性别发育障碍(DSD)的致病基因。MAMLD1/Mamld1 在胎儿睾丸中表达,并被预测能增强几种睾丸间质细胞特异性基因的表达。迄今为止,半合子 MAMLD1 变体已在多个外生殖器低雄性化的 46,XY 个体中被发现。致病性 MAMLD1 变体可能导致出生时的生殖器异常,并可能与睾丸功能随年龄恶化有关。此外,一些 MAMLD1 变体已在卵巢功能障碍的 46,XX 个体中被发现。然而,最近的研究提出了 MAMLD1 变体作为多基因疾病导致 46,XY DSD 和卵巢功能障碍的可能性。MAMLD1 尚未解决的问题包括 MAMLD1 变体与 46,XX 睾丸 DSD 之间的关联、MAMLD1 介导的 DSD 发育中的基因-基因相互作用以及 MAMLD1 的细胞内功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验